Rahat Malhotra, MD, Resident Headshot

Rahat Malhotra, MD, Resident

Tata Memorial Hospital
Mumbai, Maharashtr

Radiation Oncologist · Medical App Developer


LinkedIn · X · Instagram · Medium









NTCP calculator and Re-irradiation App radrisk.app




CLINICAL EXPERIENCE










Senior Resident



August 2023 – April 2026



Tata Memorial Hospital, Mumbai










Junior Resident



July 2020 – July 2023



Tata Memorial Hospital, Mumbai










Intern



January 2018 – January 2019



Government Medical College & Rajindra Hospital, Patiala



EDUCATION










MD, Radiation Oncology



July 2020 – July 2023



Tata Memorial Hospital, Mumbai










MBBS



August 2013 – December 2017



Government Medical College, BFUHS, Patiala


PUBLICATIONS



  • Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study.

  • Validation testing of OUTPATSAT-35RT questionnaire to assess satisfaction in patients on outpatient radiotherapy in a large Indian cohort.


CONFERENCE PRESENTATIONS



  • Poster & abstract — MAGENTA study, ISNOCON 2023, Kolkata, India.

  • Poster — Outcomes of HDR Brachytherapy for Early-stage Penile Cancer, IBSCON, Gurgaon, India, August 2024.

  • Poster — Outcomes of Solitary Fibrous Tumors of the CNS (SOFT), SNO/WFNOS, Honolulu, Hawaii, November 2025.


CERTIFICATIONS & MEMBERSHIPS



  • Member — Association of Radiation Oncologists of India (AROI).

  • Member — Asian Society of Neuro-Oncology (ASNO).

  • Member — Indian Society of Neuro-Oncology (ISNO).


SKILLS



  • Adept at teamwork and multidisciplinary collaboration.

  • Willingness to acquire new knowledge, skills, and experiences.

  • Loves to code, currently learning machine learning (R & Python).


AWARDS & ACHIEVEMENTS



  • Participation in Neuro-oncology Quiz, ISNOCON 2023, Kolkata.

  • Kishore Vaigyanik Protsahan Yojana (KVPY) Scholar — 2012.

  • Bronze Medal, 16th National Science Congress, Dimapur, 2008.

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none